Case Challenges in nAMD and DME Management: Achieving Durable Response

Access Activity

Overview / Abstract:

The management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with intravitreal anti-vascular endothelial growth factor (VEGF) therapies has provided enhanced visual outcomes for many patients. However, the high treatment burden associated with anti-VEGF therapies can lead to lack of patient adherence, resulting in suboptimal outcomes. Personalized treatment protocols using FDA-approved agents and newer novel delivery systems, along with agents with unique mechanisms of action, have been developed to address the treatment burden by extending the interval between dosing of treatment while providing visual acuity gains. In this case-based CE and COPE activity, experts in the field evaluate treatment protocols that offer increased efficacy, safety, and durability in patients with nAMD and DME and provide guidance for practices and procedures that can improve patient adherence to therapeutic regimens.


May 30, 2024


Optometry / Ophthalmology CE


Webinar / Webcast / Video

Credits / Hours



This continuing education activity is provided by Vindico Medical Education.

Presenters / Authors / Faculty

Carl Danzig,

Jordan Graff

Michael Singer,

Ferhina Ali,

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Keywords / Search Terms

Vindico Medical Education namd, dme, management Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map